Concepedia
Statistics
Publications
6
Citations
116
H-Index
Active since
2007
Affiliations
Astellas Pharma (Japan)(Current)
The University of Tokyo
Tohoku Institute of Technology
Takafumi Shirakawa is an author at Astellas Pharma (Japan) specializing in neuropharmacology, medicine, and pharmacology.
Top concepts
MedicinePharmacologyNeuropharmacologyCell DeathNeuroscienceNeurochemistryNeurologyPhysiologyToxicologyCell Biology
Publications per year
2007–2022
Raster plots machine learning to predict the seizure liability of drugs and to identify drugs
Naoki Matsuda, Aoi Odawara, Kosuke Kinoshita et al. · Scientific Reports · 2022 · 29 citations · Full text
Principal Component Analysis to Distinguish Seizure Liability of Drugs in Human iPS Cell-Derived Neurons
Yasuyuki Ishibashi, Aoi Odawara, Kosuke Kinoshita et al. · Toxicological Sciences · 2021 · 24 citations · Full text
Synaptic Transmission, Neurophysiological Biomarkers, Neurotransmission +23
FK506-protective effects against trimethyltin neurotoxicity in rats: Hippocampal expression analyses reveal the involvement of periarterial osteopontin
M. Morita, Hideki Imai, Yongxun Liu et al. · Neuroscience · 2008 · 22 citations
Fk506-protective Effects, Medicine, Physiology +11
Temporospatial patterns of COX-2 expression and pyramidal cell degeneration in the rat hippocampus after trimethyltin administration
Takafumi Shirakawa, Kenji Nakano, Naomi Hachiya et al. · Neuroscience Research · 2007 · 18 citations
Medicine, Cell Death, Neuropharmacology +7
Investigation of Mechanisms for MK-801-Induced Neurotoxicity Utilizing Metabolomic Approach
Kanae Kuroda, Ken‐ichi Suzumura, Takafumi Shirakawa et al. · Toxicological Sciences · 2015 · 12 citations
1–5 of 6